Literature DB >> 19816053

Levels of IL-1beta and IL-1ra in cerebrospinal fluid of human patients after single and prolonged seizures.

Kai A Lehtimäki1, Tapani Keränen, Johanna Palmio, Jukka Peltola.   

Abstract

BACKGROUND: Experimentally induced seizures are associated with increased production of inflammatory cytokines in the nervous system. Elevated cerebrospinal fluid levels of cytokine interleukin-6 (IL-6) have been found after a single generalized seizure in human patients. After prolonged seizures, levels of IL-6 have been shown to be even higher compared with single seizures. In the present study, we determined the levels of proconvulsive IL-1beta and anticonvulsive IL-1ra in cerebrospinal fluid after single tonic-clonic seizures as well as after prolonged seizures.
METHODS: The levels of cytokines were measured using enzyme-linked immunosorbent assay.
RESULTS: We found that after single seizures, a slight increase in anticonvulsive IL-1ra levels was found; however, after prolonged partial or recurrent tonic-clonic seizures, the levels of IL-1ra were significantly elevated, together with decreased IL-1beta levels.
CONCLUSION: Our results indicate that after severe seizures, the balance between IL-1-type cytokines is changed towards a neuroprotective and anticonvulsive direction with an overproduction of IL-1ra with respect to potentially neurotoxic IL-1beta. This reaction may serve as a defense mechanism of the nervous system against excitotoxic neuronal damage. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19816053     DOI: 10.1159/000243081

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  12 in total

Review 1.  Cytokines and brain excitability.

Authors:  Michael A Galic; Kiarash Riazi; Quentin J Pittman
Journal:  Front Neuroendocrinol       Date:  2011-12-27       Impact factor: 8.606

Review 2.  Inflammatory pathways of seizure disorders.

Authors:  Nicola Marchi; Tiziana Granata; Damir Janigro
Journal:  Trends Neurosci       Date:  2013-12-16       Impact factor: 13.837

Review 3.  Inflammation in Epileptic Encephalopathies.

Authors:  Oleksii Shandra; Solomon L Moshé; Aristea S Galanopoulou
Journal:  Adv Protein Chem Struct Biol       Date:  2017-02-28       Impact factor: 3.507

4.  Chemotactic and mitogenic stimuli of neuronal apoptosis in patients with medically intractable temporal lobe epilepsy.

Authors:  Milan Fiala; Hripsime Avagyan; Jose Joaquin Merino; Michael Bernas; Juan Valdivia; Araceli Espinosa-Jeffrey; Marlys Witte; Martin Weinand
Journal:  Pathophysiology       Date:  2012-03-22

Review 5.  Targeting inflammation as a therapeutic strategy for drug-resistant epilepsies: an update of new immune-modulating approaches.

Authors:  Giovanna Vitaliti; Piero Pavone; Fahad Mahmood; Giuseppe Nunnari; Raffaele Falsaperla
Journal:  Hum Vaccin Immunother       Date:  2014-03-07       Impact factor: 3.452

Review 6.  Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.

Authors:  Charles A Dinarello; Anna Simon; Jos W M van der Meer
Journal:  Nat Rev Drug Discov       Date:  2012-08       Impact factor: 84.694

7.  The TARC/sICAM5 Ratio in Patient Plasma is a Candidate Biomarker for Drug Resistant Epilepsy.

Authors:  John R Pollard; Ofer Eidelman; Gregory P Mueller; Clifton L Dalgard; Peter B Crino; Christopher T Anderson; Elizabeth J Brand; Evren Burakgazi; Sai K Ivaturi; Harvey B Pollard
Journal:  Front Neurol       Date:  2013-01-03       Impact factor: 4.003

8.  Gabapentin administration reduces reactive gliosis and neurodegeneration after pilocarpine-induced status epilepticus.

Authors:  Alicia Raquel Rossi; Maria Florencia Angelo; Alejandro Villarreal; Jerónimo Lukin; Alberto Javier Ramos
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

9.  Early Gabapentin Treatment during the Latency Period Increases Convulsive Threshold, Reduces Microglial Activation and Macrophage Infiltration in the Lithium-Pilocarpine Model of Epilepsy.

Authors:  Alicia Rossi; Veronica Murta; Jerónimo Auzmendi; Alberto Javier Ramos
Journal:  Pharmaceuticals (Basel)       Date:  2017-11-28

Review 10.  Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy.

Authors:  Gaku Yamanaka; Yu Ishida; Kanako Kanou; Shinji Suzuki; Yusuke Watanabe; Tomoko Takamatsu; Shinichiro Morichi; Soken Go; Shingo Oana; Takashi Yamazaki; Hisashi Kawashima
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.